Today, the American Parkinson Disease Association (APDA) announced 25 grants to support cutting-edge PD research for the 2025-2026 funding year, a 55% increase from last year.  The newly-funded research projects span a wide range of key areas in PD research, including the propagation and degradation of alpha-synuclein, synaptic lipid imbalances in synucleinopathies, and the identification of genetic and circuit-based therapeutic targets.  Congratulations to Stanford’s Gaurav Chattree, MD, who received the George C. Cotzias Fellowship, given to a young neurologist.  Dr. Chattree’s project focuses on novel therapeutic strategies for pathologic circuits in Parkinson’s.  This fellowship is named in honor of the scientist who had a critical role in developing Levodopa as a treatment for PD. 

Read about Dr. Chattree and his research project

Read about all 25 research grantees

George C. Cotzias Fellowship

The George C. Cotzias Fellowship is named in honor of the scientist who had a critical role in developing Levodopa as a treatment for Parkinson’s disease and is awarded with the purpose of encouraging young neurologists to follow in his footsteps.

Gaurav Chattree, MD
The Board of Trustees of the Leland Stanford Junior University
Developing Novel Therapeutic Strategies for Pathologic Circuits in Parkinson’s Disease